The Value of the CDC Lipid Standardization Program
CDC in USA has worked for more than 50 years to standardize lipid and lipoprotein measurements to improve public health. Early efforts focused on developing a reference system, including reference measurement procedures and reference materials to use in the Lipid Standardization Program. Not only has this important infrastructure program permitted comparisons of clinical and epidemiological studies, but it has also allowed researchers to recognize long-term population trends in lipids and lipoproteins. Furthermore, the Lipid Standardization Program has provided a uniform basis for patient selection and data interpretation in clinical and epidemiological studies.
Topics of this article:
- Adult Treatment Panel (ATP) III panels
- ApoB: Missing in Action?
- Reference Measurement Procedures
- Homogeneous Direct Method Issues
- Implementing Direct Homogeneous Assays
- Effect of Method on Risk Assessment
- Triglyceride Measurements
- Future Guidelines
Read full article:
November 2011 Clinical Laboratory News: Lipids and Lipoproteins
Learn more and strengthen your expertise
External quality assessment schemes (EQA) for lipids and lipoproteins